{"type":"img","src":"\r\nhttps://cdn.quv.kr/jkq7tqr31%2Fup%2F69cc670dce4ed_1920.png","height":40}
  • HOME
  • About
  • R&D
  • Exosome Technology
  • Products
  • Manufacturing Lines
  • Contact Us
  • {"google":["PT Sans"],"custom":["Noto Sans KR"]}
    ×
    섹션 설정
    {"type":"img","src":"//cdn.quv.kr/jkq7tqr31/up/69cc670dce4ed_1920.png","height":36}
  • HOME
  • About
  • R&D
  • Exosome Technology
  • Products
  • Manufacturing Lines
  • Contact Us
  • R&D

    R&D

    R&D Overview

    BioScience Korea conducts continuous research and development in collaboration with leading research institutes,

    leveraging FreSHtracer™ technology to advance high-quality cell-based therapeutics and biomedical solutions

    for chronic, degenerative, and immune-related diseases.

    Chronic inflammatory & fibrotic diseases

    Cell therapies utilizing high-quality stem cells with enhanced anti-inflammatory and anti-fibrotic functions.

    Respiratory diseases (Asthma)

    FreSHtracer™-selected MSC lines validated in multiple asthma animal models.

    Degenerative joint diseases (Osteoarthritis)

    Cartilage regeneration and aging microenvironment modulation confirmed in OA animal models.

    Immunological disorders (GVHD)

    High-GRC MSCs showing superior efficacy in GVHD models(Science Advances, 2020).

    Neurological & autoimmune diseases

    Cell therapies utilizing Nrf2 pathway activation–based stem cell therapies for myelin-related disorders.

    Veterinary regenerative medicine

    Clinical validation through treatment of over 500 companion animals.

    {"google":["PT Sans"],"custom":["Noto Sans KR"]}{"google":["PT Sans","Questrial","Lato"],"custom":["Noto Sans KR","Tmon Monsori"]}
    {"google":[],"custom":["Noto Sans KR"]}